Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status

Detalles Bibliográficos
Autores principales: Shea, Lauren K., Honjo, Kazuhito, Redden, David T., Tabengwa, Edlue, Li, Ran, Li, Fu-Jun, Shakhmatov, Mikhail, Chiorazzi, Nicholas, Davis, Randall S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520396/
https://www.ncbi.nlm.nih.gov/pubmed/31092813
http://dx.doi.org/10.1038/s41408-019-0207-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520396/
https://www.ncbi.nlm.nih.gov/pubmed/31092813
http://dx.doi.org/10.1038/s41408-019-0207-7

Ejemplares similares